Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57941-70-5

Post Buying Request

57941-70-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57941-70-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 57941-70-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,9,4 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57941-70:
(7*5)+(6*7)+(5*9)+(4*4)+(3*1)+(2*7)+(1*0)=155
155 % 10 = 5
So 57941-70-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H18O3/c1-2-12-10(11)8-13-9-6-4-3-5-7-9/h9H,2-8H2,1H3

57941-70-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-cyclohexyloxyacetate

1.2 Other means of identification

Product number -
Other names cyclohexyloxyacetic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57941-70-5 SDS

57941-70-5Relevant articles and documents

Production device and method of high-content cyclic Grifola ester synthetic perfume (by machine translation)

-

Paragraph 0040-0043, (2020/01/25)

The invention discloses a production device of high-content cyadoop synthetic perfume and a method for, producing the cyclohexyloxy acetic acid through the saponification, and O - H acidification of, the high-content cyclic Grifola (, cyclohexanone). (by machine translation)

Method for synthesizing high-content galbanum oxyacetate fragrance

-

Paragraph 0040; 0042; 0049; 0051, (2019/12/25)

The invention discloses a method for synthesizing a high-content galbanum oxyacetate fragrance. The method replaces the Williamson reaction, and includes perform an O-H insertion reaction of ethyl diazoacetate and cyclohexanol under catalysis of a catalyst Rh2(OAc)4 to obtain ethyl cyclohexyloxyacetate, saponifying and acidifying to obtain cyclohexyloxyacetic acid, and esterifying with allyl alcohol to obtain galbanum oxyacetate. The method can greatly shorten the reaction time. In addition, a prepared solid acid catalyst Yb-MoO3/Al2O3-ZrO2 has the advantages of easy separation from a liquid phase reaction system, no corrosion on equipment and simple post-treatment, which overcomes the problems of corrosion of the existing liquid acid on the equipment and pollution of acid-containing wastewater on the environment; the catalyst has high selectivity, and can be applied at low temperatures, so as to save energy consumption, reduce occurrence of side reactions, and can greatly improve production efficiency, and the content of the prepared galbanum oxyacetate fragrance is as high as 99.6%; and the catalyst is good in thermal stability, and active components are not easy to lose, so thecatalyst has good reusability and is a new green catalytic material with great application potentials.

Nitrogenous Heterocyclic Derivatives And Their Application In Drugs

-

Paragraph 0861, (2015/03/31)

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57941-70-5